Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Haemophilus influenzae Type B Infections - Overview
Haemophilus influenzae Type B Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Haemophilus influenzae Type B Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Haemophilus influenzae Type B Infections - Companies Involved in Therapeutics Development
AIM Vaccine Co Ltd
AVM Biotechnology LLC
Beijing Minhai Biotechnology Co Ltd
Biken Co Ltd
Biological E Ltd
Cadila Healthcare Ltd
CanSino Biologics Inc
Changchun Heber Biotechnology Co Ltd
Chongqing Zhifei Biological Products Co Ltd
GlaxoSmithKline Plc
Hilleman Laboratories Pvt Ltd
KM Biologics Co Ltd
Liaoning Cheng Da Biotechnology Co Ltd
Novo Medi Sciences Pvt Ltd
Olymvax Biopharmaceuticals Inc
Orlance Inc
Pacea Biotec Ltd
Serum Institute of India Pvt Ltd
Shantha Biotechnics Pvt Ltd
Suzhou Weichao Biotechnology Co Ltd
Tuck-More Biotechnology Co Ltd
Vaxxilon AG
Wellstat Vaccines LLC
Yisheng Biopharma Co Ltd
Haemophilus influenzae Type B Infections - Drug Profiles
(diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis (acellular,adsorbed) + rotavirus + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis + tetanus) (pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenza [serotype B] + meningococcal + pertussis (acellular) + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + Haemophilus influenza [serotype B] + pertussis (acellular) + polio + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenza [serotype B] + pertussis (acellular) + poliomyelitis + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + Haemophilus influenza [serotype B] + pertussis (acellular) + tetanus) (tetravalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] + pertussis (whole cell) + poliomyelitis + tetanus) (heptavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + tetanus) (pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + Haemophilus influenzae [serotype B] + pertussis (acellular) + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + Haemophilus influenzae [serotype B] + pertussis (whole cell) + polio + tetanus)(pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenzae [serotype B] + pertussis (whole cell) + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + tetanus + pertussis (acellular) + haemophilus influenzae [serotype B]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae [serotype B]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(Haemophilus influenzae [serotype B] + meningococcal [serotypes A, C]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(Haemophilus influenzae B + Neisseria meningitidis [serotypes A, C, Y, W135]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(meningococcal [4-valent] + hemophilus influenzae [serotype B]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BK-1310 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dexamethasone sodium phosphate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
haemophilus influenza B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
haemophilus influenza B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
haemophilus influenzae [serotype B] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
haemophilus influenzae [serotype B] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
haemophilus influenzae [serotype B] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Haemophilus influenzae B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Haemophilus influenzae B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Haemophilus influenzae B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Haemophilus influenzae B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
influenza vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
influenza vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
influenza vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KD-370 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LT-Hib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Haemophilus influenzae Type B Infections - Dormant Projects
Haemophilus influenzae Type B Infections - Discontinued Products
Haemophilus influenzae Type B Infections - Product Development Milestones
Featured News & Press Releases
Jan 07, 2019: Biomedical Sciences researcher gets $3.26 million grant to develop universal flu vaccine
Jun 24, 2015: Hilleman Laboratories? preclinical trial report on Hib vaccine offers hope to millions of children
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Haemophilus influenzae Type B Infections, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Haemophilus influenzae Type B Infections, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Haemophilus influenzae Type B Infections - Pipeline by AIM Vaccine Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by AVM Biotechnology LLC, 2021
Haemophilus influenzae Type B Infections - Pipeline by Beijing Minhai Biotechnology Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Biken Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Biological E Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Cadila Healthcare Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by CanSino Biologics Inc, 2021
Haemophilus influenzae Type B Infections - Pipeline by Changchun Heber Biotechnology Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Chongqing Zhifei Biological Products Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by GlaxoSmithKline Plc, 2021
Haemophilus influenzae Type B Infections - Pipeline by Hilleman Laboratories Pvt Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by KM Biologics Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Liaoning Cheng Da Biotechnology Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Novo Medi Sciences Pvt Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Olymvax Biopharmaceuticals Inc, 2021
Haemophilus influenzae Type B Infections - Pipeline by Orlance Inc, 2021
Haemophilus influenzae Type B Infections - Pipeline by Panacea Biotec Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Serum Institute of India Pvt Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Shantha Biotechnics Pvt Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Suzhou Weichao Biotechnology Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Tuck-More Biotechnology Co Ltd, 2021
Haemophilus influenzae Type B Infections - Pipeline by Vaxxilon AG, 2021
Haemophilus influenzae Type B Infections - Pipeline by Wellstat Vaccines LLC, 2021
Haemophilus influenzae Type B Infections - Pipeline by Yisheng Biopharma Co Ltd, 2021
Haemophilus influenzae Type B Infections - Dormant Projects, 2021
Haemophilus influenzae Type B Infections - Dormant Projects, 2021 (Contd..1)
Haemophilus influenzae Type B Infections - Discontinued Products, 2021